2016
DOI: 10.1002/slct.201600173
|View full text |Cite
|
Sign up to set email alerts
|

Selection of High Affinity Peptides for Prediction of Colorectal Adenoma-to-Carcinoma Progression

Abstract: Human leucine‐rich α‐2‐glycoprotein 1 (LRG1) and tumor necrosis factor (TTR) have shown a highly valued biomarker for predicting tumor progression in colorectal cancer. The level of both biomarkers in plasma was correlated with the progression to severe colon cancer. In this paper, we describe for the first time the use of phage display for the identification of novel peptide motifs that specifically recognize colon cancer biomarkers for the prediction of colorectal adenoma‐to‐carcinoma progression. The peptid… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 21 publications
0
5
0
Order By: Relevance
“…Using this approach, our group recently reported a new electrochemical phage-based sensor for the detection of various targets [3740]. Therefore, free peptides, not associated with whole M13 phages, may utilize as alternative recognition reagent for the creation of a peptide-decorated electrochemical sensor for the early diagnosis of virus infection or target of interest [38, 39]. Therefore, affinity peptides can act as specific recognition element over antibodies in point-of-care testing because of their structural versatility, specificity and high binding affinity for targets [40].…”
Section: Introductionmentioning
confidence: 99%
“…Using this approach, our group recently reported a new electrochemical phage-based sensor for the detection of various targets [3740]. Therefore, free peptides, not associated with whole M13 phages, may utilize as alternative recognition reagent for the creation of a peptide-decorated electrochemical sensor for the early diagnosis of virus infection or target of interest [38, 39]. Therefore, affinity peptides can act as specific recognition element over antibodies in point-of-care testing because of their structural versatility, specificity and high binding affinity for targets [40].…”
Section: Introductionmentioning
confidence: 99%
“…A new approach for the early diagnosis of CRC in plasma samples from patients with adenomas and carcinomas used synthetic affinity peptides identified by the phage display technique [145]. Synthetic peptides were selectively bound to the leucine-rich α-2-glycoprotein 1 (LRG1) that was overexpressed in CRC patients, and the level of plasma LRG1 was related to the progression of CRC from the adenoma stage to carcinoma [146]. Four series of specific peptides that recognize the LRG1 protein were synthesized to be different in some amino acids and modified with a C-terminal cysteine and a flexible connector (-GGGGS-) to form a SAM on gold electrodes.…”
Section: Electrochemical Biosensing Of Protein Biomarkers Of Crcmentioning
confidence: 99%
“…ELISA may also be applied to study affinity between target and phage-displayed ligand (e.g. peptide) [13][14][15][16][17][18] .…”
Section: Introductionmentioning
confidence: 99%